Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/25748
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCosters, Lars-
dc.contributor.authorGielen, Jeroen-
dc.contributor.authorEelen, Piet L.-
dc.contributor.authorvan Schependom, Jeroen-
dc.contributor.authorLaton, Jorne-
dc.contributor.authorVan Remoortel, Ann-
dc.contributor.authorVANZEIR, Ellen-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorSeeldrayers, Pierrette-
dc.contributor.authorHaelewyck, Marie-Claire-
dc.contributor.authorD'Haeseleer, Miguel-
dc.contributor.authorD'hooghe, Marie-Beatrice-
dc.contributor.authorLangdon, Dawn-
dc.contributor.authorNagels, Guy-
dc.date.accessioned2018-03-09T14:12:39Z-
dc.date.available2018-03-09T14:12:39Z-
dc.date.issued2017-
dc.identifier.citationMULTIPLE SCLEROSIS AND RELATED DISORDERS, 18, p. 33-40-
dc.identifier.issn2211-0348-
dc.identifier.urihttp://hdl.handle.net/1942/25748-
dc.description.abstractBackground: The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a fast, easy-to-administer and already widely validated neuropsychological battery for cognition in multiple sclerosis. Objective: The goals of our study were to validate the BICAMS in a Belgian Dutch-speaking population and to investigate to what extent including extensive versions of two of the three BICAMS subtests improved its psychometric qualities. Methods: Ninety-seven persons with MS and ninety-seven healthy controls were included and group-matched on age, education level and gender. All participants performed the BICAMS with an extensive version of the CVLT-II and BVMT-R. Results: The SDMT and BVMT-R were able to dissociate between the MS and healthy control group, while the CVLT-II was not. Distributions of CVLT-II scores suggest learning effects in the MS group, indicating the need for alternative word lists or the construction of an adapted version fitted for repeated administration. Including the full CVLT-II and BVMT-R did not markedly improve the psychometric qualities of the BICAMS. Conclusion: This study validates the BICAMS in a Belgian Dutch-speaking population and facilitates the use of it in clinical practice, while providing evidence that including full versions of the CVLT-II and BVMT-R does not increase its psychometric qualities markedly.-
dc.description.sponsorshipMD has received travel grants, consultancy and speaker fees from Biogen, Teva, Novartis and Genzyme Sanofi. DL is a consultant for Novartis, Bayer, TEVA, Biogen and Merck, part of a speaker bureau for Almirall, TEVA, Biogen, Novartis, Bayer and Excemed and holds research grants from Novartis, Biogen and Bayer. All are paid into DL's university. GN holds a research chair by Merck and Novartis. None of these are likely to be relevant in the context of this manuscript.-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.subject.otherMultiple sclerosis; Cognition; BICAMS-
dc.subject.otherMultiple sclerosis; Cognition; BICAMS-
dc.titleDoes including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study-
dc.typeJournal Contribution-
dc.identifier.epage40-
dc.identifier.spage33-
dc.identifier.volume18-
local.format.pages8-
local.bibliographicCitation.jcatA1-
dc.description.notes[Costers, Lars; Gielen, Jeroen; van Schependom, Jeroen; Laton, Jorne; D'Haeseleer, Miguel; D'hooghe, Marie-Beatrice; Nagels, Guy] Vrije Univ Brussel, Ctr Neurosci, Pleinlaan 2, B-1050 Brussels, Belgium. [Haelewyck, Marie-Claire; Nagels, Guy] Univ Mons, Fac Psychol & Sci Educ, Mons, Belgium. [Eelen, Piet L.; Van Remoortel, Ann; D'Haeseleer, Miguel; D'hooghe, Marie-Beatrice; Nagels, Guy] Natl MS Ctr Melsbroek, Steenokkerzeel, Belgium. [van Schependom, Jeroen] Vrije Univ Brussel, UZ Brussel, Radiol, Brussels, Belgium. [Vanzeir, Ellen; Van Wijmeersch, Bart] Revalidatie & MS Centrum Overpelt, Overpelt, Belgium. [Van Wijmeersch, Bart] Univ Hasselt, Biomed Onderzoeksinst, Hasselt, Belgium. [Seeldrayers, Pierrette] Ctr Hosp Univ Charleroi, Charleroi, Belgium. [Langdon, Dawn] Royal Holloway Univ London, London, England.-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.msard.2017.08.018-
dc.identifier.isi000415341300008-
item.fulltextWith Fulltext-
item.contributorCosters, Lars-
item.contributorGielen, Jeroen-
item.contributorEelen, Piet L.-
item.contributorvan Schependom, Jeroen-
item.contributorLaton, Jorne-
item.contributorVan Remoortel, Ann-
item.contributorVANZEIR, Ellen-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorSeeldrayers, Pierrette-
item.contributorHaelewyck, Marie-Claire-
item.contributorD'Haeseleer, Miguel-
item.contributorD'hooghe, Marie-Beatrice-
item.contributorLangdon, Dawn-
item.contributorNagels, Guy-
item.fullcitationCosters, Lars; Gielen, Jeroen; Eelen, Piet L.; van Schependom, Jeroen; Laton, Jorne; Van Remoortel, Ann; VANZEIR, Ellen; VAN WIJMEERSCH, Bart; Seeldrayers, Pierrette; Haelewyck, Marie-Claire; D'Haeseleer, Miguel; D'hooghe, Marie-Beatrice; Langdon, Dawn & Nagels, Guy (2017) Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study. In: MULTIPLE SCLEROSIS AND RELATED DISORDERS, 18, p. 33-40.-
item.accessRightsOpen Access-
item.validationecoom 2018-
crisitem.journal.issn2211-0348-
crisitem.journal.eissn2211-0356-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1-s2.0-S221103481730202X-main.pdf
  Restricted Access
Published version710.04 kBAdobe PDFView/Open    Request a copy
accepted_manuscript_BICAMS.pdfPeer-reviewed author version1.07 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.